Venture capital investors may not be hitting the pause button on startup financing, but they did noticeably scale back on ultra-massive rounds over the past week, with just two companies securing fundraisings in the multiple hundreds of millions of dollars.
While the broader ecosystem continues to deploy capital across artificial intelligence, biotech, climate technologies, and enterprise software, the sheer volume of megadeals contracted compared to previous weeks. The largest financing of the period went to AI infrastructure provider Modal Labs, which pulled in a staggering $750 million. Meanwhile, construction automation unicorn Icon secured $200 million, rounding out the only two deals crossing the $200 million threshold. Beyond these two giants, sectors such as biotechnology, specialized insurance, semiconductor systems, and healthcare artificial intelligence continued to attract robust, albeit smaller, early-and-late-stage investments.
The Week’s Top U.S. Funding Rounds
Topping the weekly charts is Modal Labs, a New York-headquartered provider of cloud infrastructure designed specifically for AI inference and related high-performance computing applications. The company secured $750 million in a Series D funding round led by prominent venture firm Accel. The massive infusion of capital values Modal Labs at an impressive $15.75 billion. The massive valuation reflects the company’s rapid hypergrowth, with leadership reporting that the business recently surpassed an annual revenue run rate of $1 billion, capitalizing on the insatiable global demand for scalable AI compute infrastructure.
Securing the second-largest spot for the week is Austin, Texas-based Icon. The construction technology unicorn, widely known for developing advanced robotic construction systems that utilize 3D-printing technology to build homes, closed on $200 million in Series D funding. The round was co-led by institutional heavyweights Baillie Gifford and BlackRock. Icon’s latest capital injection comes on the heels of surging market adoption, with the company projecting an aggressive fourfold increase in revenue growth throughout 2026 as it scales its automated building solutions.
The biotechnology sector also captured substantial investor attention, highlighted by Boston-based Soufflé Therapeutics. The RNA therapeutics developer successfully raised $135 million in a Series B funding round. The financing was led by Juvia Group, which anchored a large and diverse syndicate of life sciences investors looking to back the next generation of genetic medicine.
In a similar vein, the genetic medicine space saw the notable launch and early-stage backing of Estuary Biotherapeutics. Based in Menlo Park, California, the company focuses on developing advanced genetic medicines tailored for patients suffering from serious and degenerative kidney diseases. Estuary officially launched with a combined $103 million in financing. This total includes a robust $93 million Series A round led by RA Capital Management, alongside $10 million in previously undisclosed seed capital that helped lay the groundwork for the biotech startup.
Artificial intelligence tooling and enterprise software developers also maintained a steady presence on the weekly tally. Labelbox, an 8-year-old San Francisco-based developer of technology used to train, evaluate, and deploy AI models and autonomous agents that improve through real-world experience, picked up $100 million in Series E funding. The round was led by Infinitum Partners, underscoring continued investor confidence in foundational AI data operations and evaluation tooling.
Healthcare artificial intelligence continues to be a fertile ground for venture capital. Suki, a Redwood City, California-based provider of specialized AI tools capable of converting clinical conversations into structured intelligence for medical documentation, billing codes, and broader healthcare workflows, announced a $90 million Series E financing. Backers for this round included Healthier Capital and Crosslink Capital, reflecting the ongoing push to alleviate administrative burnout among healthcare professionals through ambient listening and automation.
The caregiving economy also saw a major capital injection. Abby Care, a San Francisco-based startup operating a platform that enables family members to become certified, paid caregivers delivering professional-grade care at home, closed on $82 million in Series C funding. The round for the 5-year-old platform was led by Transformation Capital, highlighting the growing intersection of healthcare, labor platforms, and family support systems.
In the insurance technology sector, Stand secured $70 million in Series C funding at a coveted $1 billion unicorn valuation. Headquartered in San Francisco, the three-year-old company specializes in providing property insurance solutions for homes located in geographical areas facing elevated risks of natural disasters. The financing was led by Saga Ventures Management, pointing to the surging demand for innovative risk-assessment and coverage models in an era marked by increasingly volatile weather patterns and climate-related insurance crises.
Hardware and infrastructure developers rounded out the upper tier of the week’s financing announcements. Mueon Corp., a Portland, Oregon-based semiconductor systems company currently building a modular platform tailored for artificial intelligence and hyperscale computing environments, completed a $65 million Series A funding round led by Maverick Silicon.
Additionally, New York-based North.cloud closed a $60 million Series B round. The company provides an infrastructure spend intelligence and automation platform designed to help enterprises manage and optimize their escalating cloud and AI operational expenditures. Peakspan Capital led the investment round.
Methodology and Market Context
The weekly funding data tracks the largest announced financing rounds captured within the Crunchbase database for U.S.-based companies during the monitoring period of October 10 through October 16, 2026. While the vast majority of significant venture capital announcements are cataloged in real time, minor time lags may occur due to rounds being publicly reported or verified late in the weekly cycle.
